Diagnostics is an exciting industry to be in partially because “under the Affordable Care Act, there will be a large influx of new patients,” says Brian Miller from Linden Capital Partners in this video conversation with Mergers & Acquisitions editor-in-chief Mary Kathleen Flynn at a roundtable sponsored by Madison Capital Funding LLC and Katten Muchin Rosenman LLP.